Share Name Share Symbol Market Type Share ISIN Share Description
Eden Research Plc LSE:EDEN London Ordinary Share GB0001646941 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 10.15p 10.00p 10.30p 10.15p 10.15p 10.15p 125,987 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 2.8 -0.5 -0.2 - 21

Eden Research Share Discussion Threads

Showing 6601 to 6621 of 7750 messages
Chat Pages: Latest  274  273  272  271  270  269  268  267  266  265  264  263  Older
DateSubjectAuthorDiscuss
23/3/2019
13:07
Tu m'a perdu la.
brucie5
23/3/2019
12:59
Je suis sur la page de retard parallèle depuis un moment maintenant et Wan a rattrapé son retard. Je suis toujours content de ce type de triangulation.
supersonico
23/3/2019
12:13
peut etre. peut etre pas.
brucie5
23/3/2019
11:10
Cela indique peut-être que la résolution parallèle est proche.
supersonico
23/3/2019
09:26
Finalement .or as JNR would say.. On dirait que nous sommes enfin parvenus à un consensus sur le retard parallèle. Espérons que tout se passe comme Lennon l'aurait dit. Conséquence de retard parallèle sur les cartes parallèles = carré parallèle. Comme Debbie aurait pu le dire avant de se contenter du dernier titre plus accrocheur.
supersonico
23/3/2019
08:02
Brucie...Not 'yet' is correct, put another way though and in my view, it's more a case of when and not if! In terms of crop protection, there are opportunities beyond pesticides e.g. biostimulants, imagine a combined product with no tank mixing necessary, or the need to spray a second product....i.e. big efficiency gains for the end user. User safety, improved product efficacy and patent extensions are all attributes of Sustaine that are probably easily overlooked, but will be a key aspect of the current evaluations. In the current environment, certain global players want (need) to improve their environmental credentials/reputations. Food for thought; given what I said about the Bayer delays and the fact that Bayer has an 'exclusive' licence to Eden's 'encapsulation technology' for the animal health sector in North America in post 285, and given that Eden has negotiated terms for the next-generation encapsulation technology, could this be a solution to the current impasse (I don't buy the additional formulation work!)? In any regard, if we get any further commentary of further formulation or marketing strategy/distribution partner type excuses (yes, as in post 285 I believe there could be a connection between animal health products and the head lice product!), then we have to assume there is more to it and push the Chairman and Board for answers! If this impasse does exist, then it implies Bayer are somewhat concerned, which in turn suggests there is a lot of latent value to be realised, either with Bayer or indeed another partner/s.
wan
22/3/2019
21:27
I am very basic chemist But we started with short term plant based polymers and then on to medium and long chain polymers ,This epiphany was 35+yrs ago. But this is for the very micro size of clay particle size when talking about encapsulation Can someone explain how long chain ,presumably sprayed chemimical polymers disable living pests of whatever sort. I’m am also interested philosophically on how wiping out pests increases or does not decrease genetic natural diversity. I want to see a food chain that is broad based not just so called protecting the birds and bees. How do you not kick the stool from under mans feet? Do you leave it to Man’s selective Wisdom
chrischas
22/3/2019
20:52
Not yet for co-encapsulation with pesticides OR solely encapsulation of others pesticides.
investingisatrickygame
22/3/2019
17:42
Wan, yes, 'banked' as far as mevalone and Cedroz, but not yet for reencapsulation of existing pesticides, am I right? As you say, potential and who shares what.
brucie5
22/3/2019
16:59
Brucie...Sipcam and Eastman have already accessed it, via Mevalone and Cedroz respectively. Therefore, it is effectively being banked already. But what is perhaps overlooked, is the validation that this provides and therefore the near certainty that there is scope to exploit the technology beyond the current markets and products. So, I don't think the jury is out on Sustaine per se, but more about extensive assessment and evaluation, how the potential is quantified and how Eden and their partners realise it 'equitably', which was never going to happen very quickly! Btw, I do make an effort to stay up to speed with regard to potential competitors etc.
wan
22/3/2019
16:22
Nematodes stealing bushels, revenue and deserve attention, experts advise hTTps://www.iasoybeans.com/news/articles/nematodes-stealing-bushels-revenue-and-deserve-attention-experts-advise/ Fast-forward 30 years and nematode reproduction and populations are on the rise. “There are two types of farmers in the Midwest,” Tylka said. “Those who are worried about SCN and those who should be.” Heck and Tylka offered their warnings and call-to-action during a panel discussion focused on the income-robbing pest held earlier this month at Commodity Classic in Orlando, Florida. Joining them in the conversation were Auburn University plant pathologist Kathy Lawrence, Albert Tenuta, plant pathologist for the Ontario (Canada) Ministry of Agriculture and farmers Kip Roberson and Pat Duncanson of North Carolina and Minnesota, respectively. Rising populations and resistance spells trouble for farmers and the soybean industry, panelists said. “The nematode is adapting to and overcoming resistance while soybean yields of SCN-resistant varieties are trending lower,” said Tylka, who also serves as director of the Iowa Soybean Research Center at ISU. “Added together, the impact could be a loss of 10-15 bushels per acre. That’s profound when considering this situation is quite likely typical for farmers throughout the Midwest.” Panelists agreed that admitting and identifying the presence of SCN is what makes it so difficult to manage. A farmer growing 60-bushel soybeans, for example, may be pleased with the output. Therefore, they’re not as inclined to ask what went wrong despite the potential to harvest 70-bushel soybeans per acre if nematode populations were suppressed. “Some growers are aware they have an issue,” said Lawrence. “But it usually takes a yield loss – and a rather severe one – for them to start looking to find out why.”
supersonico
22/3/2019
15:30
Wan: Yes to the above, but I think we have to assume that the jury is still out on Sustaine. Not that it isn't of interest; it clearly is keeping Sipcam and others very interested. But that interest doesn't become commercially bankable until we discover what they are willing to pay to access it, and on what terms. We also have to assume that technology moves on all fronts, and EDEN will not be without competitors. It's taking them a long time to make up their minds.
brucie5
22/3/2019
09:57
I'm interested to know how much of this statement from Sumiagro and Sipcam that references Sumitomo fits into Eden's Crop protection developmental Vertical pipeline and Sustaine and also the wider applications across the Sumitomo footprint. I hope an update from Eden will inform us further. It would be useful to me to understand in more depth how the SEIPRO brand works across Sumitomo partnerships globally. 'Five new features coming soon. The Japanese company also indicates that five projects are expected to be completed in the coming months, including the SAF1801i, which officials describe as "a new means of pest control through its mode of action". This solution is composed of a spectrum of polymers with different chain lengths. During its application, these polymer chains entangle and congeal on the surface of the plant. The film thus created immobilizes the pest and prevents it from feeding. "It is selective small insects little mobile, especially the sucking-type psyllid suckers, whiteflies ... It has no adverse effects on auxiliary wildlife," said the official. This solution does not require a marketing authorization because it has no insecticidal action, it has a profile without DAR and without residues. The company indicates that it has been tested on orchard, vineyard, market gardening with good results. Among the other novelties expected, a biocontrol fungicide based on microencapsulated terpenes for the fight against pome fruit conservation diseases. The biocontrol insecticide Oikos will benefit from a new formulation'. hTTp://www.arboriculture-fruitiere.com/articles/technique-fruit/quinze-nouveaux-biostimulants-homologues-sur-toutes-cultures
supersonico
22/3/2019
08:02
The problem......and the opportunity! 3Bar Biologics and Pivot Bio Team Up to Crack One of the Biggest Barriers to the Adoption of Biologicals MARCH 20, 2019 “The big issue with this sector, and why it is not growing fast enough, is that the products need to perform better in the field. Consistency and in-field performance are the industry’s Achilles’ Heel. The issue with living products like biologics is that our supply chain is designed for synthetic chemicals that can withstand long storage times and rapidly changing temperatures,” Caldwell told AgFunderNews. “One way to overcome this is with cold storage, but biologics would require cold storage all the way to the field, which just isn’t cost effective or practical.” Full story - hTTps://agfundernews.com/3bar-biologics-and-pivot-bio-team-up-to-crack-one-of-the-biggest-barriers-to-the-adoption-of-biologicals.html Cue Eden's Sustaine, but of course it is already firmly on the radar of certain global players. Put another way....Sipcam (Sumitomo and possibly Eastman), already have their foot firmly in the doorway that leads to Sustaine!
wan
21/3/2019
21:33
Pesticides on fruit, vegetables and nuts hxxps://www.thenation.com/article/pesticides-farmworkers-agriculture/
investingisatrickygame
21/3/2019
06:57
Early exposure to pesticides linked to small increased risk of autism spectrum disorder. hTTps://medicalxpress.com/news/2019-03-early-exposure-pesticides-linked-small.html
supersonico
20/3/2019
15:18
to that, add Redt, but more so. No climate to be raising funds... Which is why we need profitability here soon.
brucie5
20/3/2019
13:33
A roller coaster for sure. Disappointing for LTH but I believe a good price to get in at as I expect substantial new contract award news flow this year. Much of the gloom is based on the current numbers which I expect to be positively impacted upon by the new contracts.
supersonico
20/3/2019
12:55
SuperWhat do you make of "See" results and announcements of raising capital?Hope Eden will not do the same.
northwick
20/3/2019
08:31
What Planet is Werner Baumann on ??..aka The public just don't understand our phoney Corporate Science.. aka Trust us.. we've got cool Skate Boarder Hero's in our Bayer Leaps PR. News Bayer Loses First Phase of Roundup Trial, Now Will Face Liability hTTps://www.bloomberg.com/news/articles/2019-03-19/bayer-loses-first-phase-of-roundup-trial-now-to-face-liability Chief Executive Officer Werner Baumann has worked to restore investors’ confidence, announcing a restructuring and reporting better-than-expected earnings growth last quarter, but those efforts could easily be undone by concerns over Roundup and the health impact of its active ingredient glyphosate, said Markus Mayer, an analyst at Baader Bank AG. Bayer said moving to the next phase of Edwin Hardeman’s suit against the company has no impact on future cases because each one has its own factual and legal circumstances. “We are disappointed with the jury’s initial decision, but we continue to believe firmly that the science confirms glyphosate-based herbicides do not cause cancer,” the company said in a statement. “We are confident the evidence in phase two will show that Monsanto’s conduct has been appropriate and the company should not be liable for Mr. Hardeman’s cancer.”
supersonico
19/3/2019
21:27
carey gillam@careygillam Verdict in -jury finds for plaintiff in first phase of Monsanto @Bayer Roundup cancer trial. hTTp://news.trust.org/item/20190319210402-xry4m/ hTTps://www.theguardian.com/business/2019/mar/19/monsanto-trial-roundup-verdict-edwin-hardeman-cancer
supersonico
Chat Pages: Latest  274  273  272  271  270  269  268  267  266  265  264  263  Older
Your Recent History
LSE
EDEN
Eden Resea..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20190826 06:51:03